HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Larisa Bobrovskaya Selected Research

lipopolysaccharide A

11/2022Lipopolysaccharide mouse models for Parkinson's disease research: a critical appraisal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Larisa Bobrovskaya Research Topics

Disease

12Parkinson Disease (Parkinson's Disease)
11/2022 - 02/2011
7Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2018
5Ischemia
01/2021 - 03/2018
4Neuroinflammatory Diseases
01/2022 - 04/2020
3Inflammation (Inflammations)
01/2022 - 01/2021
3Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 01/2018
3Ischemic Stroke
12/2021 - 03/2018
3Hypoxia (Hypoxemia)
01/2021 - 01/2019
3Mood Disorders (Mood Disorder)
01/2021 - 11/2016
2Cognitive Dysfunction
01/2022 - 01/2022
2Neoplasms (Cancer)
01/2022 - 11/2019
2Amyloid Plaque
08/2021 - 01/2018
1Rheumatoid Arthritis
08/2022
1Body Weight (Weight, Body)
01/2022
1Syndrome (Syndromes)
01/2022
1Atrophy
01/2022
1Obesity
01/2022
1Depressive Disorder (Melancholia)
01/2022
1Insulin Resistance
01/2022
1Pain (Aches)
01/2022
1Frontotemporal Dementia (Semantic Dementia)
12/2021
1Motor Neuron Disease (Primary Lateral Sclerosis)
12/2021
1Nervous System Diseases (Neurological Disorders)
11/2021
1Pathologic Processes
01/2021
1Infarction (Infarctions)
10/2020
1Movement Disorders (Movement Disorder)
04/2020
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
01/2020
1Asphyxia (Suffocation)
01/2020
1Weight Loss (Weight Reduction)
01/2020
1Huntington Disease (Huntington's Disease)
01/2020
1Brain Injuries (Brain Injury)
01/2019
1Adenoma (Adenomas)
01/2019
1Mitochondrial Diseases (Mitochondrial Disease)
07/2018
1Brain Ischemia (Cerebral Ischemia)
03/2018
1Gastroparesis
01/2018
1Hyperplasia
01/2018
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2018
1Mental Disorders (Mental Disorder)
01/2016
1Fibrosis (Cirrhosis)
02/2015
1Hypotension (Low Blood Pressure)
01/2012
1Neuroblastoma
01/2010

Drug/Important Bio-Agent (IBA)

8Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 12/2015
6Proteins (Proteins, Gene)FDA Link
08/2021 - 02/2015
5LipopolysaccharidesIBA
11/2022 - 04/2020
5Amyloid beta-PeptidesIBA
12/2021 - 01/2018
5Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
07/2021 - 01/2010
5RotenoneIBA
01/2019 - 01/2015
3EnzymesIBA
01/2021 - 01/2012
3sortilinIBA
07/2019 - 01/2016
2Streptozocin (Streptozotocin)FDA Link
01/2022 - 08/2021
2EdaravoneIBA
01/2022 - 12/2021
2Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2022 - 01/2018
2CurcuminIBA
01/2022 - 11/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2019
2Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2019
2Recombinant ProteinsIBA
03/2021 - 01/2020
2scutellarinIBA
01/2021 - 01/2021
2AntibodiesIBA
10/2020 - 11/2016
2Serine (L-Serine)FDA Link
10/2019 - 01/2012
2Protein Isoforms (Isoforms)IBA
10/2019 - 01/2010
2Dopamine (Intropin)FDA LinkGeneric
10/2019 - 02/2011
2CatecholaminesIBA
07/2018 - 01/2012
1lipopolysaccharide AIBA
11/2022
1CytokinesIBA
11/2022
1Methotrexate (Mexate)FDA LinkGeneric
08/2022
1Nerve Growth Factors (Neurotrophins)IBA
01/2022
1Hormones (Hormone)IBA
01/2022
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022
1Opioid Analgesics (Opioids)IBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1Free Radical ScavengersIBA
12/2021
1Insulin (Novolin)FDA Link
08/2021
1Protein Deglycase DJ-1IBA
07/2021
1Biological ProductsIBA
01/2021
1ImmunosorbentsIBA
01/2021
1Eosine Yellowish-(YS) (Eosin)IBA
10/2020
1SynucleinsIBA
04/2020
1CorticosteroneIBA
09/2019
1Ethanol (Ethyl Alcohol)IBA
09/2019
1Dual-Specificity PhosphatasesIBA
01/2019
1Oxygen (Dioxygen)IBA
01/2019
1NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
01/2019
1VimentinIBA
01/2019
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
01/2019
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2019
1Nerve Growth Factor (NGF)IBA
01/2018
1antineoplaston A10 (A 10)IBA
01/2012
1Phosphotransferases (Kinase)IBA
01/2012
1Oxidopamine (6 Hydroxydopamine)IBA
01/2010
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2010

Therapy/Procedure

3Therapeutics
11/2021 - 01/2020
1Drug Therapy (Chemotherapy)
01/2022
1Pain Management
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
11/2021
1Transplantation
11/2021